Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
    Contact Us
  • Affiliated Brands
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    Visit JONS
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
    Visit TON
  • Healthcare Providers
  • Contribute

All Articles

Lytgobi Newest Drug Approved for Patients with FGFR2-Positive Cholangiocarcinoma
Lytgobi Newest Drug Approved for Patients with FGFR2-Positive Cholangiocarcinoma
FDA Approvals, News & Updates, Cholangiocarcinoma
October 2022 Vol 8 No 5
Read More ›
Imfinzi Approved for Advanced or Metastatic Biliary Tract Cancer
Imfinzi Approved for Advanced or Metastatic Biliary Tract Cancer
FDA Approvals, News & Updates, Gastrointestinal Cancer, Immunotherapy
October 2022 Vol 8 No 5
Read More ›
Vegzelma a New Biosimilar Approved for the Treatment of 6 Types of Solid Tumors
Vegzelma a New Biosimilar Approved for the Treatment of 6 Types of Solid Tumors
FDA Approvals, News & Updates
October 2022 Vol 8 No 5
Read More ›
Retevmo Approved for Advanced Solid Tumors with RET Fusion
Retevmo Approved for Advanced Solid Tumors with RET Fusion
FDA Approvals, News & Updates, Genetics and Genomics
October 2022 Vol 8 No 5
Read More ›
Enhertu First Drug Approved for Advanced Lung Cancer and HER2 Gene Mutation
Enhertu First Drug Approved for Advanced Lung Cancer and HER2 Gene Mutation
FDA Approvals, News & Updates, Lung Cancer
October 2022 Vol 8 No 5
Read More ›
Pemazyre Approved for Patients with FGFR1-Positive Myeloid/Lymphoid Neoplasms
Pemazyre Approved for Patients with FGFR1-Positive Myeloid/Lymphoid Neoplasms
FDA Approvals, News & Updates
October 2022 Vol 8 No 5
Read More ›
Imbruvica Now Also Approved for Children with Chronic Graft-versus-Host Disease
Imbruvica Now Also Approved for Children with Chronic Graft-versus-Host Disease
FDA Approvals, News & Updates
October 2022 Vol 8 No 5
Read More ›
Navigating Iron Deficiency Anemia: My IV Iron Treatment Guide
Navigating Iron Deficiency Anemia: My IV Iron Treatment Guide
Web Exclusives
Web Exclusives
The Navigating Iron Deficiency Anemia: My IV Iron Treatment Guide patient resource aims to empower patients and/or caregivers to actively engage in the discussion of iron deficiency anemia (IDA) and the intravenous (IV) iron treatment decision-making process. Read More ›
Education After a Diagnosis of Endometrial Cancer: The Key to Empowerment
Education After a Diagnosis of Endometrial Cancer: The Key to Empowerment
By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Endometrial Cancer, A Note From Your Navigator
August 2022 Part 1 of 2 – Endometrial Cancer Special Issue Series
Ms. Shockney offers thoughts about education after a diagnosis as the key to empowering women facing this disease. Read More ›
Treatment Options for Endometrial Cancer
Treatment Options for Endometrial Cancer
By Robin Atkinson, RN, BSN, OCN
Endometrial Cancer
August 2022 Part 1 of 2 – Endometrial Cancer Special Issue Series
There are more effective treatment options available to you today than ever before. Here, Ms. Atkinson outlines treatments by stage. Read More ›

Page 25 of 164